Valuation
- Market cap
- 0
- Revenue TTM
- $1,570,000
- Net income TTM
- $-5,300,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -337.58%
- Debt to equity
- 0.00
Trading
- Volume
- 5,100
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- —
- Stochastic %K
- —
- Beta
- 0.51
- Analysts
- —
- Price target
- $5.60
Company profile
BG Medicine, Inc., a diagnostics company, engages in the development and commercialization of novel cardiovascular diagnostic tests to address unmet medical needs in the United States, Europe, and internationally. It offers BGM Galectin-3 test, a novel diagnostic test that measures galectin-3 in blood plasma or serum; and CardioSCORE test that is designed to identify cardiovascular events, such as heart attack and st...
Show more
BG Medicine, Inc., a diagnostics company, engages in the development and commercialization of novel cardiovascular diagnostic tests to address unmet medical needs in the United States, Europe, and internationally. It offers BGM Galectin-3 test, a novel diagnostic test that measures galectin-3 in blood plasma or serum; and CardioSCORE test that is designed to identify cardiovascular events, such as heart attack and stroke. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was incorporated in 2000 and is headquartered in Waltham, Massachusetts.
- Industry
- Medical Instruments & Supplies
- Sector
- Healthcare
- Phone
- 781 890 1199
- Website
- https://www.bg-medicine.com
- Address
- 303 Wyman Street, Suite 300, Waltham, United States
Latest news
No headlines yet.
